In humans, in addition to the clinical interest in the DGAT1 enzyme as a target for obesity treatment [5–7], studies have found related roles for this enzyme in many human disorders, such diabetes [8], nonalcoholic steatohepatitis [9] and insulin resistance [10]. This evidence concerns the gene DGAT1 and obesity disorder.